Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

32.72 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income 145.493128.853181.46834.597-36.944-151.977-39.898
Depreciation & Amortization 24.11224.35923.38518.8410.2373.210.184
Deferred Income Tax -29.298-13.419-85.94326.14625.74800
Stock Based Compensation 42.60231.70526.17315.6594.6939.9091.079
Change In Working Capital 035.035-4.1060.631-11.6288.292-0.164
Accounts Receivables -8.893-19.4-19.897-12.667-17.922-4.2550
Inventory -1.835-1.0660.135-0.609-2.735-1.0880
Accounts Payables 08.9492.785-1.555-3.8044.898-0.61
Other Working Capital 046.55212.87115.46212.8338.7370.446
Other Non Cash Items 36.91212.8543.4892.6844.90955.132.057
Operating Cash Flow 219.821219.387144.46698.557-2.985-75.436-38.799
Investing Activities:
Investments In Property Plant And Equipment -1.153-0.312-40.172-100.298-2.002-127.149-1.342
Acquisitions Net -33.069-36.967141.832-100-2-520
Purchases Of Investments -105.289-127.469-110.7290000
Sales Maturities Of Investments 98.527118.3099.0690000
Other Investing Activites -26.50-141.8321002520
Investing Cash Flow -67.484-46.439-141.832-100.298-2.002-127.149-1.342
Financing Activities:
Debt Repayment -15-1.25-2-0.579.4151000
Common Stock Issued 008.84130147.62850.0850
Common Stock Repurchased 0-10000-0.167-1.132-3.2
Dividends Paid 0000000
Other Financing Activities 4.004-4.3028.841-22.081-17.71593.76924.815
Financing Cash Flow -10.996-105.5526.8417.419209.161143.76921.615
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 141.34167.3969.4755.678204.174-58.816-18.526
Cash At End Of Period 453.271311.93244.534235.059229.38125.20784.023